- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- May 2025
- 198 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 199 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 200 Pages
Global
From €2186EUR$2,490USD£1,876GBP
- Report
- April 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- March 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- July 2025
- 174 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- April 2025
- 200 Pages
Global
From €6979EUR$7,950USD£5,988GBP
- Report
- March 2025
- 131 Pages
Global
From €4257EUR$4,850USD£3,653GBP
- Report
- February 2021
- 420 Pages
United States
From €2107EUR$2,400USD£1,808GBP
- Report
- March 2025
- 92 Pages
China
From €1580EUR$1,800USD£1,356GBP
- Report
- May 2024
- 138 Pages
Global
From €5705EUR$6,499USD£4,895GBP
- Report
- May 2024
- 133 Pages
Global
From €5705EUR$6,499USD£4,895GBP
- Report
- May 2024
- 134 Pages
Global
From €5705EUR$6,499USD£4,895GBP
- Report
- May 2024
- 139 Pages
Global
From €5705EUR$6,499USD£4,895GBP
- Report
- May 2024
- 130 Pages
Global
From €5705EUR$6,499USD£4,895GBP
- Report
- May 2023
- 160 Pages
Global
From €4344EUR$4,949USD£3,728GBP

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat mental disorders such as depression, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder. It is one of the most commonly prescribed drugs for mental disorders, and is available in both generic and brand-name formulations. Fluoxetine is also used to treat premenstrual dysphoric disorder (PMDD) and is sometimes used off-label to treat other conditions such as anxiety, bipolar disorder, and post-traumatic stress disorder (PTSD).
The Fluoxetine market is highly competitive, with a number of major pharmaceutical companies offering their own branded versions of the drug. These companies are engaged in research and development activities to develop new formulations and delivery systems for Fluoxetine. Additionally, generic versions of the drug are widely available, providing an affordable alternative for patients.
Some of the major companies in the Fluoxetine market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Mylan. Show Less Read more